Unilever Vows No GSK-Sized Ventures For Foreseeable Future, Commits To Existing Brands In 2022

Opening the company’s fiscal 2021 full-year earnings call, Unilever leadership assured investors it will not make any GSK-sized offers in the foreseeable future as it commits to organic growth and reshaping its portfolio more surgically through bolt-on deals and selective disposals.